38.48
+2.41(+6.68%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
1456
First IPO Date
December 15, 2020
| Name | Title | Pay | Year Born |
| Mr. Tianhe Dai | Deputy General Manager | 0 | 1977 |
| Mr. Jun Chen | R&D Director & Non-Independent Director | 0 | 1963 |
| Ms. Qing Wang | Deputy GM & Non-Independent Director | 0 | 1967 |
| Mr. Jun Xia | Deputy GM & Secretary of the Board | 0 | 1983 |
| Mr. Shaobing Gou | Financial Director | 0 | 1977 |
| Mr. Huanxi Cui | General Manager | 0 | 1979 |
Hefei Lifeon Pharmaceutical Co., Ltd. engages research, development, production, and sales of pharmaceutical preparations and an active ingredient (APIs). It offers APIs, such as succimer, urea, paeonol, felodipine, doxazosin mesylate, zofenopril calcium, troxerutin, and sodium 2,3-dimercapto-1-propanesulfonate; medicinal preparations comprising felodipine sustained release tablets, doxazosin mesylate extended-release tablets, melbinum glipizide tablet, yiqihewei capsule, kunning granule, armillariella oral solution, paeonol ointment, urea and vitamin e cream, Kecuo Yintong gel, and Compound Golden Larch bark gel; and plant extracts, including clove oil, evening primrose oil, herba clinopodii P.E, quercetin, and dihydroquercetin. The company also operates retail chain of pharmaceuticals. Hefei Lifeon Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Hefei, China.
